Our devices are able to quantify liver stiffness, which is a physical parameter that measures a liver’s resistance to deformation. Liver stiffness highly correlates to liver fibrosis, which is the excessive accumulation of scar tissue in a liver and a key marker of chronic liver diseases and liver health condition. The measurement of liver stiffness can, therefore, be used to determine the presence and stage of liver fibrosis and when the CAP-control attenuation parameter option is used, can be determine the presence and stage of liver steatosis, which is the excess accumulation of fat in a liver and a key marker induced by “fatty liver diseases”.

These two parameters highly correlate to liver fibrosis and liver steatosis, respectively, which are key markers of the existence and progression of chronic liver diseases. 

Used for the diagnosis of liver damage, measurement of the degree of fibrosis and steatosis of the liver. Also, can be used to monitor the Liver condition during the treatment and management.